BiotechTube
Akan Biosciences

Akan Biosciences

Frederick, United States· Est.
akanbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Akan Biosciences is a private, pre-revenue biotech founded in 2018 and headquartered in Frederick, Maryland, USA. The company is developing a portfolio of adipose-derived stem cell therapies targeting a broad range of inflammatory and degenerative conditions, including osteoarthritis, wound healing, Crohn's disease, and autism. Its lead candidate, StroMel™, is in Phase 2 for knee osteoarthritis, positioning the company in the competitive but high-potential cell and gene therapy sector.

OsteoarthritisAutism Spectrum DisorderRheumatoid ArthritisWound HealingCrohn's DiseaseSports Medicine

Technology Platform

Proprietary manufacturing methods for non-expanded adult adipose-derived stem cell-based therapeutics, utilizing tissue engineering and cell-based approaches.

Opportunities

Large and growing markets in osteoarthritis, wound care, and autoimmune diseases present significant commercial potential.
Positive data from the lead Phase 2 program could validate the platform for multiple indications and attract partnership or acquisition interest.
The location in a biotech hub provides access to talent and collaborative networks.

Risk Factors

High clinical risk across a very broad and disparate pipeline, particularly the ambitious foray into autism.
Intense competition in cell therapy and osteoarthritis spaces.
Dependence on raising private capital as a pre-revenue company, coupled with the high costs and complexity of cell therapy manufacturing and clinical trials.

Competitive Landscape

The company operates in the highly competitive cell therapy and regenerative medicine arena, facing competition from large pharma (e.g., Sanofi, Novartis), established biotechs (e.g., Mesoblast), and numerous private startups. In osteoarthritis, competitors range from generic drugs and medical devices to advanced therapies like platelet-rich plasma (PRP) and other cell-based approaches.

More companies in Cell & Gene Therapy →More companies in United States →